Calvin Smith

Calvin Smith is the Head of Chemogenetic Neuromodulation at Sania Therapeutics, leading various projects and overseeing research and development. With a background in biomedical sciences and neuroscience, Calvin has previously worked as a Research Associate at UCL and a Research Fellow at the University of Leeds. Calvin's expertise also extends to teaching and supervising students in a laboratory setting. Calvin is currently pursuing a short course in Management at The London School of Economics and Political Science.